VST Price Prediction: Vistra holds above pivot as earnings strength meets fading momentum
π Vistra Corp. reported Q3 2026 GAAP net income of $1.14 billion and adjusted EBITDA of $2.378 billion, a rise of over 50% year-over-year.
π° Management lifted the midpoint for 2026 ongoing operations adjusted EBITDA guidance to $7.1-$7.5 billion and initiated 2027 guidance of $7.7-$8.5 billion.
π The board authorized an additional $1.5 billion in share repurchases to be utilized by year-end 2028.
π BMO Capital Markets cut its price target for VST to $188 from $210 while maintaining an Outperform rating.
β οΈ KeyBanc downgraded the stock to Sector Weight, expressing concern that Texas politics could unsettle the AI power-demand thesis.
π VST is trading at $125.39, holding above the $124.75 pivot but below the 20-day SMA of $135.56 and 50-day SMA of $143.68.
π Analysts are split on whether VST's earnings strength can overcome valuation concerns and policy risks in Texas.
π Technical indicators show a neutral-to-weak RSI of 40.22 and negative MACD, suggesting the stock is stabilizing but not confirming a trend reversal.
- Vistra Corp. delivered strong Q3 2026 results with GAAP net income of $1.14 billion and adjusted EBITDA rising over 50% year-over-year to $2.378 billion.
- The company lifted the midpoint for 2026 ongoing operations adjusted EBITDA guidance to a range of $7.1 billion to $7.5 billion.
- Vistra initiated 2027 guidance with ongoing operations adjusted EBITDA expected between $7.7 billion and $8.5 billion.
- The board authorized an additional $1.5 billion in share repurchases, signaling confidence in cash generation and commitment to capital returns.
- KeyBanc downgraded the stock to Sector Weight, citing concerns that Texas politics could disrupt the data-center and AI-driven power-demand thesis.
- BMO Capital Markets cut its price target for VST from $210 to $188, reflecting a more cautious valuation outlook despite the earnings beat.
- The stock remains below key moving averages including the 20-day SMA at $135.56 and 50-day SMA at $143.68, indicating lingering technical weakness.